Current impact of adjuvant chemotherapy in resectable cancer Anna RossiG. Bonadonna General Review Pages: 7 - 16
Antibodies as specific carriers for chemotherapeutic agents Fook H. LeeKou M. Hwang Short Review Pages: 17 - 24
Mathematical modeling —Guide to high-dose methotrexate infusion therapy S. D. Reich Original Articles Pages: 25 - 31
Pharmacokinetics of bleomycin in man D. S. AlbertsHsiao-Sheng G. ChenS. E. Salmon Original Articles Pages: 33 - 40
Agents affecting osteolysis in patients with breast cancer R. C. CoombesA. Munro NevilleT. J. Powles Original Articles Pages: 41 - 44
Phase-II trial of tamoxifen in advanced breast cancer R. G. WiggansP. V. WoolleyP. S. Schein Original Articles Pages: 45 - 48
Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck S. DavisW. Kessler Original Articles Pages: 57 - 59
Ftorafur: A self-limiting source of 5-fluorouracil? L. M. van PuttenP. LelieveldF. Spreafico Original Articles Pages: 61 - 66
A new steroidal alkylating agent with improved activity in advanced murine leukemias P. CatsoulacosD. PolitisG. L. Wampler Original Articles Pages: 67 - 70